ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Autologous Tumor-infiltrating Lymphocytes GT307

Its studies are led by Grit Biotechnology.

Drug pageAutologous Tumor-infiltrating Lymphocytes GT307: every studyAll 4 studies of it, academic ones too, with its approvals, label and forms.
Furthest: no phase, since Apr 30, 20244 company-led studies, 3 open or runningNext primary completion: Apr 18, 2027

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Grit Biotechnology43 open or runningno phasesince Apr 30, 2024Apr 30, 2024Apr 18, 2027NCT06397963

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Apr 30, 2024First study: no phase study in Solid Tumor, AdultFirst studyNCT06397963 · 18 planned · China
  2. Jun 7, 2024No phase study in AdultNCT06453057 · 18 planned · China
  3. Feb 5, 2025No phase study in AdultNCT06819280 · 18 planned · China
  4. Mar 31, 2026No phase study in Advanced Solid TumorsNCT07534813 · China

Ahead

  1. Apr 18, 2027Primary completion: no phase study in Solid Tumor, AdultNCT06397963
  2. May 27, 2027Primary completion: no phase study in AdultNCT06819280
  3. Jun 6, 2027Primary completion: no phase study in AdultNCT06453057

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07534813Advanced Solid Tumors · China–WithdrawnMay 31, 20280
NCT06819280Adult · China–RecruitingMay 27, 202718
NCT06453057Adult · China–RecruitingJun 6, 202718
NCT06397963Solid Tumor, Adult · China–RecruitingApr 18, 202718

How it is read

Names in the registry

  • “GT307 injection”, 4 entries

Conditions, from the studies’ own filings

    First seen by our ledger Nov 13, 2026.

    What this can’t show

    • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
    • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
    • Primary completion dates are the sponsors’ estimates and often move.
    • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.